ProstaLund AB Sustainability Reports
ProstaLund AB is a medical technology company that specializes in developing, manufacturing, and marketing treatments for benign prostatic hyperplasia. Its core offering is CoreTherm, a patented and long-acting thermotherapy technique for treating enlarged prostates.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300E8DQ5IX5LJ5I21
FIGI: BBG001T1Q068
14 reports from 2010 to 2024
